Analysis MYCELX Technologies Corporation (MYX)
5/25/2024
Analysis of MYCELX Technologies Corporation (MYX)
MYCELX Technologies Corporation (MYX) has shown a strong uptrend in the past few days, with the price closing at $65.00 on the most recent trading day. The Relative Strength Index (RSI) is indicating overbought conditions at 78.49, suggesting a potential reversal or correction in the near future.The Moving Average Convergence Divergence (MACD) indicator is bullish, with the MACD line above the signal line and a positive MACD histogram. This indicates that the bullish momentum is strong and likely to continue.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, supporting the bullish outlook for MYX.
Overall, MYCELX Technologies Corporation seems to be in a strong bullish trend, but traders should be cautious of the overbought RSI levels and potential for a correction in the short term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to have a compound annual growth rate (CAGR) of 11%.
- However, in the past 5 years, the company had a higher growth rate with a CAGR of approximately 20.1%.
Overall, the company is expected to maintain a positive growth trajectory, with a slightly higher growth rate in the next 5 years compared to the current and upcoming quarters.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and forward PE ratio, with the company's market capitalization and enterprise value also provided. The price to book and price to sales ratios are on the higher side, indicating potentially overvalued stock.
The stock price summary includes beta, moving averages, and the range of prices over the past year. Dividends and splits data show the company's dividend history, payout ratio, and dividend yield metrics.
Overall, the data provides a comprehensive overview of the company's financial health, stock performance, valuation, and dividend policy.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2020: Sales of $274,515,000,000
2. Fiscal Year 2021: Sales of $365,817,000,000
3. Fiscal Year 2022: Sales of $394,328,000,000
4. Fiscal Year 2023: Sales of $383,285,000,000
From the data, we can observe the following trends:
- The company experienced a steady increase in revenue from 2020 to 2022, with a slight decrease in 2023.
- The highest revenue was recorded in 2022, with a total of $394,328,000,000.
- Despite the decrease in revenue in 2023 compared to 2022, the company's sales remained relatively high.
These insights provide an overview of the company's revenue performance over the past four fiscal years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching the highest value of $290,437,000,000 in 2023.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its growth, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been financing its growth through a combination of liabilities and shareholders' equity, with both showing an increasing trend over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
4. Investing activities include significant amounts related to the sale and purchase of investments, with fluctuations in capital expenditures.
5. The end cash position has varied over the years, reaching its highest value in 2020.
6. Interest paid and income tax paid figures show variations, impacting the overall cash flow position.
7. The company has been consistent in paying dividends and managing its cash flow from operating, investing, and financing activities.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing growth compared to the year-ago EPS figures, indicating optimism among analysts regarding the company's performance.
MACD of MYX
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
